Fundraising Fox

Allermi

3 known investors

allermi.com ↗

Allermi offers custom prescription nasal sprays combining up to four active ingredients to treat nasal allergies (rhinitis), delivered via online allergist consultations and home delivery. It serves adult allergy sufferers in select US states through a direct-to-consumer telehealth model.

Digital HealthDirect to ConsumerHealthtech

Founders & leadership

SIShuba Iyengar
Shuba IyengarinFounder

Investors · 3

Evolution VC PartnersNew York
Nelstone Venturesvia Rich Nelson · inferred
Origin VenturesSan Francisco · $500K – $5M

In the news

Allermi Raises $3.5M in Seed Funding | citybizcitybiz.co · Mar 2023Allermi Raises $3.5M in Seed Funding To Grow DTC Allergy Relief Platform - MedCity Newsmedcitynews.com · Mar 2023Allermi takes aim at chronic allergy symptoms with new service, funding - Bizwomenbizjournals.com · Mar 2023Online allergy startup Allermi secures $3.5M funding — TFNtechfundingnews.com · Mar 2023Allermi Secures $3.5M in Seed Funding to Meet Growing Demand for Customized Approach to Allergy Symptoms | AP Newsapnews.com · Mar 2023Shani Bocian - Kitcasterkitcaster.com

Frequently asked questions

What does Allermi do?
Allermi offers custom prescription nasal sprays combining up to four active ingredients to treat nasal allergies (rhinitis), delivered via online allergist consultations and home delivery. It serves adult allergy sufferers in select US states through a direct-to-consumer telehealth model.
Who founded Allermi?
Allermi was founded by Shuba Iyengar.
Who are Allermi's investors?
Allermi's investors include Evolution VC Partners, Nelstone Ventures, Origin Ventures.